Fact CheckerSign in

NCT07805330Recruiting

Effects of Blood Flow Restriction Rehabilitation on Functional Mobility and Balance Among Chronic Obstructive Pulmonary Disease Patients.

Effects of Blood Flow Restriction Rehabilitation on Functional Mobility and Balance Among Chronic Obstructive Pulmonary Disease Patients

Source: ClinicalTrials.gov · Last updated 4 Sept 2026

Brief summary (registry, in English)

Background: Chronic obstructive pulmonary disease (COPD) is a common lung disease causing restricted airflow and breathing problems. It is sometimes called emphysema or chronic bronchitis. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. BFR Rehabilitation is effective in improving functional mobility and balance among COPD patients. Objective: To find out the effects of Blood Flow Restriction (BFR) Rehabilitation on functional mobility and balance among COPD (Chronic Obstructive Pulmonary Disease) patients. Methods: A Randomized Controlled Trial Study was conducted at Gulab Devi Hospital, Hameed Latif Hospital and Arif Memorial Teaching Hospital Lahore. Fifty patients of age 45-60 years with COPD were randomized into two groups. Allocation of patients in two equal groups by lottery method will be through random assignment. Group A was treated with controlled physical therapy while Group B was treated with BFR rehabilitation. Controlled treatment includes low intensity resistance exercises while BFR Rehabilitation includes use of a tourniquet with low intensity resistance exercises. All this information will be collected through a pulse oximeter. Berg Balance Scale will be used for balance and timed up and go test for functional mobility.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
21 Aug 2026
Start date
24 Jun 2026
Primary completion date
24 Sept 2026
Lead sponsor
Rashid Latif Medical College
Diseases
COPD
NCT number
NCT07805330

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 24 Jun 2026 to the primary completion date, 24 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Upper abdominal surgery

Other illness

  • Lung cancer
  • Mental disorder
  • Active malignancy
  • Severe hypertension

Other

  • Open fracture

Who the study is looking for

  • Subjects who are clinically stable before study
  • Forced expiratory volume in 1s (FEV1)/forced vital capacity (FVC)\<70% and FEV1 ≥30% but \<80% respectively
  • Subjects who will be willing to take part in this study

Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Arif memorial teaching hospital
Coordinator of this site? Confirm its status
LahorePakistanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.